Please use this identifier to cite or link to this item: http://repository.tma.uz/xmlui/handle/1/5741
Full metadata record
DC FieldValueLanguage
dc.contributor.authorКаримов М.М., Зуфаров П.С., Собирова Г.Н., Исмаилова Ж.А., Дусанова Н.М.-
dc.date.accessioned2023-01-12T03:27:22Z-
dc.date.available2023-01-12T03:27:22Z-
dc.date.issued2022-
dc.identifier.issn2181-5887-
dc.identifier.urihttp://repository.tma.uz/xmlui/handle/1/5741-
dc.description.abstractIt has been shown that in patients with GERD and functional dyspepsia, the use of proton pump inhibitors leads to a decrease in heartburn and pain behind the sternum. However, symptoms such as regurgitation, belching, feeling of early satiety and heaviness after eating were stopped ineffectively. The inclusion in the treatment complex of the prokinetic domperidone at a dose of 10 mg 3 times a day contributed to a more effective regression of symptoms of impaired motility of the esophagus and stomach.en_US
dc.language.isootheren_US
dc.publisherТерапевтический вестникм Узбекистанаen_US
dc.relation.ispartofseries;УДК: 616.33-002.44-615.831-085.2-
dc.subjectgastroesophageal reflux disease, functional dyspepsia, proton pump inhibitors, prokineticsen_US
dc.titleОПТИМИЗАЦИЯ ТЕРАПИИ ГАСТРОЭЗОФАГЕАЛЬНОЙ РЕФЛЮКСНОЙ БОЛЕЗНИ ПРИ КОМОРБИДНОСТИ С ФУНКЦИОНАЛЬНОЙ ДИСПЕПСИЕЙen_US
dc.typeArticleen_US
Appears in Collections:Thesis, Articles

Files in This Item:
File Description SizeFormat 
20. TERAPIYA Jurnal N4_2022 (119-123).pdf20478.03 kBAdobe PDFView/Open


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.